Clinical trial shows remdesivir speeds up recovery of advanced Covid-19 patients

A lab technician visually inspects a filled vial of investigational coronavirus disease (COVID-19) treatment drug remdesivir at a Gilead Sciences facility in La Verne, California, US on March 11, 2020. - Gilead Sciences/AP

WASHINGTON (Xinhua): Hospitalised patients with advanced Covid-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a release from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) on Wednesday (April 29).

The conclusion came out of preliminary data analysis from a randomised, controlled trial involving 1,063 patients, which began on Feb. 21.